The story of Viagra, initially marketed by copyright, presents a complex case study for investors considering the healthcare landscape . Although its groundbreaking success and creation of vast in revenue , the exclusivity end has opened the floodgates for alternative medications, significantly reducing profit opportunities. This change raises ques